Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

NCT00699322 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Sitagliptin
DRUG: Glimepiride

Sponsor

The Catholic University of Korea

Collaborators

[object Object]